← TruNorth

Karyopharm Therapeutics vs Syndax Pharmaceuticals

On overall TruNorth grade, Syndax Pharmaceuticals scores higher (Karyopharm Therapeutics: B, Syndax Pharmaceuticals: A). Both graded from public records across nine values categories.

B
Karyopharm Therapeutics
60.6/100
A
Syndax Pharmaceuticals
72.1/100

Political donations

Karyopharm Therapeutics

FEC: $713K in executive political donations; partisan lean split across 15 executive donors.

Syndax Pharmaceuticals

FEC: $558K in executive political donations; partisan lean split across 14 executive donors.

Environment

Karyopharm Therapeutics

No public record found.

Syndax Pharmaceuticals

No public record found.

Labor

Karyopharm Therapeutics

No public record found.

Syndax Pharmaceuticals

No public record found.

DEI

Karyopharm Therapeutics

No public record found.

Syndax Pharmaceuticals

No public record found.

Charity

Karyopharm Therapeutics

No public record found.

Syndax Pharmaceuticals

No public record found.

Animal testing

Karyopharm Therapeutics

No public record found.

Syndax Pharmaceuticals

No public record found.

Firearms

Karyopharm Therapeutics

No public record found.

Syndax Pharmaceuticals

No public record found.

Privacy

Karyopharm Therapeutics

No public record found.

Syndax Pharmaceuticals

No public record found.

Executive pay

Karyopharm Therapeutics

CEO total compensation $2.1M (2024; other named executives averaged $1.1M) — SEC pay-versus-performance disclosure (Item 402(v) XBRL).

Syndax Pharmaceuticals

CEO-to-median-worker pay ratio 19:1 (median employee pay $383,252) — SEC proxy statement (DEF 14A, 2026).

Compare any two brands on the values you care about — personalized to your 30-second quiz.

Open TruNorth →